AbbVie is a global biopharmaceutical company dedicated to advancing health through innovative therapies and solutions. With a strong focus on immunology, oncology, neuroscience, and virology, AbbVie offers a diverse range of products designed to improve patients' lives. Key offerings include HUMIRA, a leading treatment for autoimmune conditions, and IMBRUVICA, an effective therapy for certain cancers.

The company also provides a variety of ophthalmic solutions like ACULAR and ALPHAGAN, which are designed to address eye-related issues. Additionally, AbbVie’s portfolio features products such as BOTOX for aesthetic treatments and various medications for chronic conditions like thyroid disorders and gastrointestinal diseases. Committed to research and development, AbbVie continually strives to bring effective and safe therapies to market, enhancing patient care.

With a robust product lineup that spans multiple therapeutic areas, AbbVie remains at the forefront of addressing some of the most pressing health challenges today, showcasing its dedication to improving health outcomes worldwide